hVIVO chief scientific officer to speak at World Vaccine Congress 

Dr Andrew Catchpole, chief scientific officer of hVIVO PLC, is set to deliver a presentation at the World Vaccine Congress in Washington DC.

His presentation - titled 'Challenge Studies, Can the Results be Expected to Mimic Field Trial Data?' - will take place on 5 April.

hVIVO chief executive Yamin 'Mo' Khan said: "I am delighted that Andrew will be presenting at the largest vaccine event of the year amongst many other notable speakers, discussing the significant value of human challenge trial data."

The event will be held at the Walter E. Washington Convention Center between April 3-6. During the congress, hVIVO representatives will be available for potential partnering discussions at booth 813.

Organised by Terrapin, the World Vaccine Congress is the largest and longest-running event dedicated to vaccines, now in its 23rd year.

The congress covers the entire vaccine value chain, from basic research to commercial manufacturing, and brings together leading global vaccine developers, academics and policymakers.

hVIVO, formerly known as Open Orphan PLC, is listed on the AIM and Euronext markets under the symbol HVO and is a world leader in human challenge clinical trials and specialist contract research organisation (CRO).